Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

Similar articles for PubMed (Select 24217937)

1.

Long-term remission and recurrence rates after first and second transsphenoidal surgery for Cushing's disease: care reality in the Munich Metropolitan Region.

Dimopoulou C, Schopohl J, Rachinger W, Buchfelder M, Honegger J, Reincke M, Stalla GK.

Eur J Endocrinol. 2013 Dec 21;170(2):283-92. doi: 10.1530/EJE-13-0634. Print 2014 Feb.

2.

Prospective evaluation of transsphenoidal pituitary surgery in 108 patients with Cushing's disease.

Rollin G, Ferreira NP, Czepielewski MA.

Arq Bras Endocrinol Metabol. 2007 Nov;51(8):1355-61.

3.

Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing's disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience.

Hameed N, Yedinak CG, Brzana J, Gultekin SH, Coppa ND, Dogan A, Delashaw JB, Fleseriu M.

Pituitary. 2013 Dec;16(4):452-8. doi: 10.1007/s11102-012-0455-z.

PMID:
23242860
4.

Endoscopic transsphenoidal pituitary surgery: a good and safe primary treatment option for Cushing's disease, even in case of macroadenomas or invasive adenomas.

Wagenmakers MA, Boogaarts HD, Roerink SH, Timmers HJ, Stikkelbroeck NM, Smit JW, van Lindert EJ, Netea-Maier RT, Grotenhuis JA, Hermus AR.

Eur J Endocrinol. 2013 Aug 28;169(3):329-37. doi: 10.1530/EJE-13-0325. Print 2013 Sep.

5.

Management of Cushing's disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging.

Prevedello DM, Pouratian N, Sherman J, Jane JA Jr, Vance ML, Lopes MB, Laws ER Jr.

J Neurosurg. 2008 Oct;109(4):751-9. doi: 10.3171/JNS/2008/109/10/0751.

PMID:
18826366
6.

Outcomes and management of patients with Cushing's disease without pathological confirmation of tumor resection after transsphenoidal surgery.

Pouratian N, Prevedello DM, Jagannathan J, Lopes MB, Vance ML, Laws ER Jr.

J Clin Endocrinol Metab. 2007 Sep;92(9):3383-8. Epub 2007 Jun 26.

PMID:
17595252
7.

Outcome of Cushing's disease following transsphenoidal surgery in a single center over 20 years.

Hassan-Smith ZK, Sherlock M, Reulen RC, Arlt W, Ayuk J, Toogood AA, Cooper MS, Johnson AP, Stewart PM.

J Clin Endocrinol Metab. 2012 Apr;97(4):1194-201. doi: 10.1210/jc.2011-2957. Epub 2012 Jan 25.

PMID:
22278423
8.

Repeated transsphenoidal pituitary surgery (TS) via the endoscopic technique: a good therapeutic option for recurrent or persistent Cushing's disease (CD).

Wagenmakers MA, Netea-Maier RT, van Lindert EJ, Timmers HJ, Grotenhuis JA, Hermus AR.

Clin Endocrinol (Oxf). 2009 Feb;70(2):274-80. doi: 10.1111/j.1365-2265.2008.03334.x.

PMID:
18616702
9.

Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.

Yap LB, Turner HE, Adams CB, Wass JA.

Clin Endocrinol (Oxf). 2002 Jan;56(1):25-31.

PMID:
11849243
10.

Results of repeated transsphenoidal surgery in Cushing's disease. Long-term follow-up.

Valderrábano P, Aller J, García-Valdecasas L, García-Uría J, Martín L, Palacios N, Estrada J.

Endocrinol Nutr. 2014 Apr;61(4):176-83. doi: 10.1016/j.endonu.2013.10.008. Epub 2013 Dec 17.

PMID:
24355549
11.

Recurrence of Cushing's disease after primary transsphenoidal surgery in a university hospital in Korea.

Kim JH, Shin CS, Paek SH, Jung HW, Kim SW, Kim SY.

Endocr J. 2012;59(10):881-8. Epub 2012 Jun 22.

12.

Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease.

Storr HL, Afshar F, Matson M, Sabin I, Davies KM, Evanson J, Plowman PN, Besser GM, Monson JP, Grossman AB, Savage MO.

Eur J Endocrinol. 2005 Jun;152(6):825-33.

13.

The usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imaging.

Testa RM, Albiger N, Occhi G, Sanguin F, Scanarini M, Berlucchi S, Gardiman MP, Carollo C, Mantero F, Scaroni C.

Eur J Endocrinol. 2007 Feb;156(2):241-8.

14.

Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome?

Chee GH, Mathias DB, James RA, Kendall-Taylor P.

Clin Endocrinol (Oxf). 2001 May;54(5):617-26.

PMID:
11380492
15.

Transsphenoidal surgery for Cushing's disease: endocrinological follow-up monitoring of 82 patients.

Shimon I, Ram Z, Cohen ZR, Hadani M.

Neurosurgery. 2002 Jul;51(1):57-61; discussion 61-2.

PMID:
12182435
16.

[Predictors of long-term remission after transsphenoidal surgery in Cushing's disease].

Abellán Galiana P, Fajardo Montañana C, Riesgo Suárez PA, Gómez Vela J, Escrivá CM, Lillo VR.

Endocrinol Nutr. 2013 Oct;60(8):475-82. doi: 10.1016/j.endonu.2012.09.009. Epub 2012 Dec 23. Spanish.

PMID:
23266144
17.

Evaluation of Cushing's disease remission after transsphenoidal surgery based on early serum cortisol dynamics.

Costenaro F, Rodrigues TC, Rollin GA, Ferreira NP, Czepielewski MA.

Clin Endocrinol (Oxf). 2014 Mar;80(3):411-8. doi: 10.1111/cen.12300. Epub 2013 Sep 4.

PMID:
23895112
18.
19.

Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease.

Patil CG, Veeravagu A, Prevedello DM, Katznelson L, Vance ML, Laws ER Jr.

Neurosurgery. 2008 Aug;63(2):266-70; discussion 270-1. doi: 10.1227/01.NEU.0000313117.35824.9F.

PMID:
18797356
20.

Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease.

Acebes JJ, Martino J, Masuet C, Montanya E, Soler J.

Acta Neurochir (Wien). 2007;149(5):471-7; discussion 477-9. Epub 2007 Apr 5.

PMID:
17406780
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk